The smoker's - A hemodynamic reality?;Paradoxo dos fumadores - Uma realidade hemodinâmica?

Revista Portuguesa de Cardiologia

Volumn 23, Issue 4, 2004, Pages 547-555

  Bettencourt, Nuno ^a,b   Mateus, Pedro ^a   Dias, Carla ^a   Santos, Lino ^a   Adão, Luís ^a   Gonçalves, Carlos ^a   Simões, Lino ^a   Gama, Vasc ^a  

^a CENTRO HOSPITALAR DE VILA NOVA DE GAIA ESPINHO   (Portugal)

^b NONE   (Portugal)

Author keywords

Acute coronary syndrome; Hemodynamics; Paradox; Smoking

Indexed keywords

TROPONIN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; ELECTROCARDIOGRAM; FEMALE; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PROGNOSIS; SMOKING; THROMBOGENICITY;

ADULT; AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; SMOKING; SYNDROME;

EID: 2942659105     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Angeja BG, Kermgard S, Chen MS et al. The smoker's paradox: insights from the angiographic substudies of the TIMI trials. J Thromb Thrombolysis 2002;13(3):133-9.
2. Gourlay SG, Rundle AC, Barron HV. Smoking and mortality following myocardial infarction: results from the National Registry of Myocardial Infarction 2. Nicotine Tob Res 2002; 4(1):101-7.
3. Andrikopoulos GK, Richter DJ, Dilaveris PE et al. In-hospital mortality of habitual cigarette smokers after acute myocardial infarction: the "smoker's paradox" in a countrywide study. Eur Heart J 2001;22(9):776-84
4. Himbert D, Juliard JM, Golmard JK et al. Revision of the "smoker's paradox": smoking is not a good prognostic factor immediately after myocardial infarction. Arch Mal Couer Vaiss 2001;94(4):262-8.
5. Purcell IF, Newall N, Farrer M. Lower cardiac mortality in smokers following thrombolysis for acute myocardial infarction may be related to more effective fibrinolysis. Q J Med 1999;92:327-33.
6. Cho L, Bhatt DL, Wolski K et al. Effect of smoking status and abciximab use on outcome after percutaneous coronary revascularization: pooled analysis from EPIC, EPILOG and EPISTENT. Am Heart J 2001;141(4):599-602.
7. Grines CL, Topol EJ, O'Neill WW et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation 1995;91:298-303.
8. Sonke GS, Stewart AW, Beaglehole R et al. Comparison of case fatality in smokers and non-smokers after acute cardiac event. Br Med J 1997;315:992-3.
9. Barbash GI, Reiner J, White HD et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. J Am Coll Cardiol. 1995;26:1222-9.
10. Cohen DJ, Doucet M, Cutlip D et al. Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention. Another Smoker's Paradox? Circulation 2001;14:773-8.